Your browser doesn't support javascript.
loading
Medication fill duration in pediatric hypertension: adherence, blood pressure control, and disparities.
McLaughlin, Meghan M; Gleber, Conrad D; Wang, Hongyue; Halterman, Jill S; Lande, Marc B.
Afiliación
  • McLaughlin MM; Department of Pediatrics, University of Rochester Medical Center, Pediatric Nephrology, 601 Elmwood Ave, Box 777, Rochester, NY, 14642, USA. Meghan_McLaughlin@URMC.Rochester.edu.
  • Gleber CD; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Wang H; Department of Biostatistics, University of Rochester Medical Center, Rochester, NY, USA.
  • Halterman JS; Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA.
  • Lande MB; Department of Pediatrics, University of Rochester Medical Center, Pediatric Nephrology, 601 Elmwood Ave, Box 777, Rochester, NY, 14642, USA.
Pediatr Nephrol ; 39(9): 2717-2723, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38597974
ABSTRACT

BACKGROUND:

Medication nonadherence is a barrier to hypertension control. The Centers for Disease Control and Prevention recommends prescribing 90-day fills for maintenance medications yet antihypertensives are often dispensed as 30-day fills. Our objectives were to examine how often patients receive 30-day supplies of medication despite prescriptions for longer duration and to examine the effect of medication fill duration on adherence and hypertension control.

METHODS:

We conducted a retrospective cohort study of pediatric patients with hypertension over a 3-year period. For each patient, days prescribed per fill were compared to days dispensed per fill using pharmacy reports and insurance claim data. Proportion of Days Covered (PDC) was calculated to estimate adherence. Hypertension control was determined by provider assessment of control and blood pressure measurement at the final visit.

RESULTS:

Final cohort included 449 patients. A total of 70% had at least one prescription for ≥ 90 days but only 37% had at least one dispense for ≥ 90 days. There was no difference in the likelihood of being prescribed a 90-day fill by insurance type (public vs. private); however, patients with public insurance were less likely to be dispensed a 90-day fill (OR = 0.068, p < 0.001). Patients who received 90-day fills had better adherence (median PDC 77.5% vs. 58.1%, p < 0.001) and were more likely to have hypertension control based on provider assessment.

CONCLUSIONS:

Longer fill duration is associated with improved adherence and hypertension control. Patients with public insurance are markedly less likely to be dispensed 90-day fills, a modifiable barrier to improving adherence.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_desigualdade_iniquidade / 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Presión Sanguínea / Cumplimiento de la Medicación / Hipertensión / Antihipertensivos Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Nephrol Asunto de la revista: NEFROLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_desigualdade_iniquidade / 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Presión Sanguínea / Cumplimiento de la Medicación / Hipertensión / Antihipertensivos Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Nephrol Asunto de la revista: NEFROLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...